CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.
The topics and banter at this year’s Sohn Investment Conference offered a glimpse at what is on the minds of top fund managers.
Centene (CNC) is back in focus after reporting first quarter results showing higher revenue, net income, and earnings per share compared with a year earlier, along with raised 2026 revenue and GAAP diluted EPS guidance. See our latest analysis for Centene. The strong first quarter and raised 2026 guidance have coincided with a sharp shift in sentiment. A 59.01% 1 month share price return and a modest 0.58% 1 year total shareholder return suggest that momentum has recently picked up after a...
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...
Greenlight Capital's David Einhorn pitched two investment ideas Tuesday at the Sohn Investment Conference that he says are undervalued beneficiaries of the artificial-intelligence boom: Centene: The managed-care company can use AI to speed up manually repetitive processes such as claims processing, Einhorn said.
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Here is how Centene (CNC) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year.
Though Centene has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
When Centene Corporation reported its first-quarter results in late April, the numbers told two stories that seemed impossible to reconcile. The St. Louis-based insurer had hemorrhaged customers, watching its Affordable Care Act marketplace membership collapse from 5.6 million to 3.6 million in just one year — a drop of roughly 2 million people. Yet the ... This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here’s how
We just covered 15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026 and Centene Corporation (NYSE:CNC) ranks 1st on this list. Centene Corporation (NYSE:CNC) recently posted Q1 2026 results that significantly cleared the high bar set by institutional expectations. The company delivered an Adjusted EPS of $3.37 on $49.94 billion in revenue, far exceeding […]
The Morning Bull - US Market Morning Update Wednesday, Apr, 29 2026 E-mini S&P 500 futures are little changed, with a gain of about 0.01%, as investors weigh steady interest rates against rising costs and geopolitical risks. The US Federal Reserve is expected to keep its key rate on hold, while the 10 year Treasury yield sits near 4.35%, a level that keeps borrowing costs for mortgages, credit cards, and businesses relatively high. At the same time, oil is in focus after US crude stockpiles...
Shares of health coverage company Centene (NYSE:CNC) jumped 14.6% in the afternoon session after the company reported first-quarter 2026 results that surpassed analyst expectations and raised its full-year financial guidance.
Oracle stock slumps following a report that major partner OpenAI missed its own user and revenue targets.